Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15291404rdf:typepubmed:Citationlld:pubmed
pubmed-article:15291404lifeskim:mentionsumls-concept:C0024432lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C0023779lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C0003209lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C0015689lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C0762662lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C1327413lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C1523116lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C1515999lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C1550147lld:lifeskim
pubmed-article:15291404lifeskim:mentionsumls-concept:C1709305lld:lifeskim
pubmed-article:15291404pubmed:issue4lld:pubmed
pubmed-article:15291404pubmed:dateCreated2004-8-4lld:pubmed
pubmed-article:15291404pubmed:abstractTextOmega-3 lipid pretreatment significantly decreases TNF-alpha production in LPS-stimulated Mphis; however, this response is only a partial inhibition, suggesting that other nonsubstrate- (lipid) dependent mechanisms are involved. The cyclooxygenase (COX)-2 enzyme is principally responsible for lipid metabolism; thus, a selective COX-2 inhibitor (Rofecoxib) would clarify if it is an omega-3 lipid direct effect or a COX-2 enzyme-associated modulated reduction in TNF-alpha. Moreover, potential synergy between omega-3 lipids and selective COX-2 inhibition is postulated.lld:pubmed
pubmed-article:15291404pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:languageenglld:pubmed
pubmed-article:15291404pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:citationSubsetIMlld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15291404pubmed:statusMEDLINElld:pubmed
pubmed-article:15291404pubmed:issn0148-6071lld:pubmed
pubmed-article:15291404pubmed:authorpubmed-author:ZhaoYou-YangY...lld:pubmed
pubmed-article:15291404pubmed:authorpubmed-author:HeltonW...lld:pubmed
pubmed-article:15291404pubmed:authorpubmed-author:EspatN...lld:pubmed
pubmed-article:15291404pubmed:authorpubmed-author:AnwarKhandake...lld:pubmed
pubmed-article:15291404pubmed:authorpubmed-author:BabcockTricia...lld:pubmed
pubmed-article:15291404pubmed:issnTypePrintlld:pubmed
pubmed-article:15291404pubmed:volume28lld:pubmed
pubmed-article:15291404pubmed:ownerNLMlld:pubmed
pubmed-article:15291404pubmed:authorsCompleteYlld:pubmed
pubmed-article:15291404pubmed:pagination232-9; discussion 239-40lld:pubmed
pubmed-article:15291404pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:meshHeadingpubmed-meshheading:15291404...lld:pubmed
pubmed-article:15291404pubmed:articleTitleSynergistic anti-inflammatory activity of omega-3 lipid and rofecoxib pretreatment on macrophage proinflammatory cytokine production occurs via divergent NF-kappaB activation.lld:pubmed
pubmed-article:15291404pubmed:affiliationDepartment of Surgery, University of Illinois at Chicago, Chicago, Illinois 60612, USA.lld:pubmed
pubmed-article:15291404pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15291404pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed